General practice management of type 2 diabetes
Diabetes is a national health priority. The number of people with type 2 diabetes is growing, most likely the result of rising overweight and obesity rates, lifestyle and dietary changes, and an ageing population. Within 20 years, the number of people in Australia with type 2 diabetes may increase from an estimated 870,000 in 2014, to over 2.5 million.1 The most socially disadvantaged Australians are twice as likely to develop diabetes.
If left undiagnosed or poorly managed, type 2 diabetes can lead to coronary artery disease (CAD), stroke, kidney failure, limb amputations and blindness. The early identification and optimal management of people with type 2 diabetes is therefore critical. General practice has the central role in type 2 diabetes management across the spectrum, from identifying those at risk right through to caring for patients at the end of life. These guidelines support general practitioners (GPs) and their teams to provide high-quality management by providing up-to-date, evidence-based information tailored for general practice.
In the development of the 2014–15 edition of General practice management of type 2 diabetes, the RACGP has focused on factors relevant to current Australian clinical practice. The RACGP has used the skills and knowledge of your general practice peers who have an interest in diabetes management and are members of the RACGP’s National Faculty of Specific Interests Diabetes Network.
This edition represents 18 years of a successful relationship between the RACGP and Diabetes Australia. We acknowledge the support of the RACGP National Standing Committee – Quality Care, the Medical Education and Scientific Committee of Diabetes Australia, and RACGP staff in the development of these guidelines. We would also like to acknowledge the contribution of the previous editorial panel (Dr Pat Phillips, Dr Peter Harris, Dr Linda Mann and Ms Carole Webster), whose dedication and commitment to previous editions has been instrumental to the success of these guidelines.
- Shaw J, Tanamas S, eds. Diabetes: the silent pandemic and its impact on Australia. Melbourne: Baker IDI Heart and Diabetes Institute, 2012.
3Screening, risk assessment, case finding and diagnosis
5Structured care and patient education
7Evaluating the patient with diabetes
10Managing microvascular and other complications
12Diabetes, multimorbidity and medication complications
13Diabetes and reproductive health
14Management of other impacts of diabetes